Tesamorelin: Research Reference Hub
Last updated
Reference hub for Tesamorelin as a research-use laboratory material: compound identity, analytical characteristics, batch evidence and handling. Not for human or veterinary use.
Compound identity
| Quantity | 10 mg |
|---|---|
| Unit | 1 Vial |
| Purity data | ≥98% |
| Salt form | Acetate |
| Sequence | trans-3-hexenoic acid-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2 |
| Molecular mass | 5135.86 |
| CAS number | 218949-48-5 |
| Solubility | Sterile / Bacteriostatic water 1ml/vial |
Batch evidence
A listed report exists for batch QYA055, tested 2026-06-01, purity shown 98.27%. View the independent report.
Supply form and handling
Supplied lyophilised in a sealed, clearly labelled vial (10mg). Store sealed, cold and protected from light and moisture. Reconstitution follows the institution’s validated procedure; see reconstitution and storage.
What this page is not
This hub is laboratory reference information. It does not provide protocols, dosing, administration guidance, or any statement about effect, benefit or suitability for people or animals.
Related references
Tesamorelin product page · Tesamorelin buyer guide · Certificate of Analysis · HPLC purity · Research-use policy